Answers are grounded in this paper and cite their sources.
Shows a rise in factor VIII inhibitors following prothrombin complex concentrate infusions in hemophilia A, highlighting risks of anamnestic immune responses.
Factor VIII inhibitor levels were measured on 261 occasions in 76 hemophilia-A inhibitor patients before and after prothrombin complex concentrate infusion at 13 treatment centers. A rise in inhibitor level to at least twice the pretreatment value occurred in 35 treatment episodes (13.5%), in 27 patients (36%). In 16 patients (21%), such an anamnestic immune response occurred with the first treatment. Factors predisposing to anamnestic responses may include patient idiosyncrasy, low pretreatment inhibitor levels, and exposure to concentrate over several days.
No takes yet. Share an insight, caveat, or question.
Kasper Ck (1979) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: